Jennifer Jarrett bought stock once, on Sep 25, 2026

Jennifer Jarrett is the Chief Operating Officer (COO) at Arcus Biosciences, Inc. (RCUS), a clinical-stage biopharmaceutical company focused on developing oncology therapeutics.( She previously served as COO and CFO at Arcus, playing a key role in its initial public offering, before briefly joining Uber as Vice President of Corporate Development and Capital Markets, and has been a board member since January 2019.( Earlier, she was CFO at Medivation until its 2016 acquisition by Pfizer.( Jarrett spent 20 years in investment banking, including as Managing Director at Citigroup leading the west coast life sciences group, and roles at Credit Suisse, Donaldson, Lufkin & Jenrette, Merrill Lynch, and Kidder Peabody.(

She holds a B.A. in Economics from Dartmouth College and an M.B.A. from the Stanford Graduate School of Business.( Jarrett serves on the boards of Sagimet Biosciences, Syndax Pharmaceuticals, Zura Bio, and LifeMine Therapeutics, among others.(

Written by Perplexity from public sources.